Related Experiment Video

Updated: Jun 19, 2026

A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance
05:19

A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance

Published on: November 7, 2025

The Optimal Application of Prostate-Specific Antigen (PSA) Velocity to Predict High-Risk Disease

Stacy Loeb1, Anna Kettermann, Luigi Ferrucci

  • 1Department of Urology (SL, AK, PL, HBC), The Johns Hopkins University School of Medicine, The James Buchanan Brady Urological Institute, Baltimore, Maryland, and the National Institute on Aging (NIA), National Institutes of Health (NIH), Clinical Research Branch (LF, EJM), Baltimore, Maryland.

European Urology
|November 4, 2009
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer13:19

Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer

Published on: November 2, 2013

A Cognitive Fusion-guided Prostate Biopsy Using Multiparametric Magnetic Resonance Imaging and Transrectal Ultrasound06:08

A Cognitive Fusion-guided Prostate Biopsy Using Multiparametric Magnetic Resonance Imaging and Transrectal Ultrasound

Published on: March 21, 2025

Related Concept Videos

Sensitivity, Specificity, and Predicted Value01:13

Sensitivity, Specificity, and Predicted Value

In healthcare diagnostics, laboratory tests play a crucial role in identifying and diagnosing a wide range of medical conditions. However, interpreting test results is not always straightforward. An abnormal test result does not always confirm the presence of a disease, just as a normal result does not guarantee its absence. To assess the reliability of these diagnostic tools, healthcare practitioners rely on two key statistical indicators: sensitivity and specificity.
Sensitivity is the...